Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gordon

Showing results (1201-1210 of 1,291) with videos related to

Pageof 130
Sort By:
Scientific Reports|September 15, 2021
The nose is the best niche for detection of experimental pneumococcal colonisation in adults of all ages, using nasal washElissavet Nikolaou, Esther L German, Annie Blizard, et al.
Mucosal Immunology|July 1, 2024
Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adultsBritta C Urban, André N A Gonçalves, Dessi Loukov, et al.
Vaccine|February 10, 2020
Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynxCaz Hales, Simon P Jochems, Rachel Robinson, et al.
Vaccine|October 9, 2022
Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisationAsia-Sophia Wolf, Elena Mitsi, Scott Jones, et al.
BMJ Open|July 7, 2022
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2019
Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial PathogensElena Mitsi, Beatriz Carniel, Jesús Reiné, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignanciesKaren W L Yee, Anne Hagey, Srdan Verstovsek, et al.
Pharmacogenetics and Genomics|May 15, 2013
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751Federico Innocenti, Jacqueline Ramírez, Jennifer Obel, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 15, 2017
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDYEliza B Geer, Ismat Shafiq, Murray B Gordon, et al.
Human Genetics|November 20, 2018
Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutationsDavor Lessel, Ayse Bilge Ozel, Susan E Campbell, et al.
Pageof 130

Showing results (1201-1210 of 1,291) with videos related to

Sort By:
Pageof 130
Scientific Reports|September 15, 2021
The nose is the best niche for detection of experimental pneumococcal colonisation in adults of all ages, using nasal washElissavet Nikolaou, Esther L German, Annie Blizard, et al.
Mucosal Immunology|July 1, 2024
Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adultsBritta C Urban, André N A Gonçalves, Dessi Loukov, et al.
Vaccine|February 10, 2020
Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynxCaz Hales, Simon P Jochems, Rachel Robinson, et al.
Vaccine|October 9, 2022
Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisationAsia-Sophia Wolf, Elena Mitsi, Scott Jones, et al.
BMJ Open|July 7, 2022
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2019
Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial PathogensElena Mitsi, Beatriz Carniel, Jesús Reiné, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignanciesKaren W L Yee, Anne Hagey, Srdan Verstovsek, et al.
Pharmacogenetics and Genomics|May 15, 2013
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751Federico Innocenti, Jacqueline Ramírez, Jennifer Obel, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 15, 2017
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDYEliza B Geer, Ismat Shafiq, Murray B Gordon, et al.
Human Genetics|November 20, 2018
Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutationsDavor Lessel, Ayse Bilge Ozel, Susan E Campbell, et al.
Pageof 130